HolderBook

EFFECTOR THERAPEUTICS INC (EFTRW)

Institutional ownership reported to the SEC as of Q2 2024, across 12 quarters.

12
Reporting holders
$3.5K
Reported value
2.5%
Held as options
-3
Holder change

Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.

Holders

FilerValueShares Their book Held Change
ARISTEIA CAPITAL, L.L.C.$1.6K1,303,6460.00%12q-2.2%
GOLDMAN SACHS GROUP INC$757630,5390.00%12qHELD
WHITEBOX ADVISORS LLC$358298,1450.00%12qHELD
SUSQUEHANNA INTERNATIONAL GROUP, LLP$241200,5570.00%2q+1094.2%
MMCAP International Inc. SPC$175145,9410.00%12qHELD
Parallel Advisors, LLC$7764,1660.00%11qHELD
MILLENNIUM MANAGEMENT LLC$67options only0.00%12qOPTIONS
UBS Group AG$6463,6450.00%3q+9782.8%
III Capital Management$4536,5790.00%12q-12.5%
TENOR CAPITAL MANAGEMENT Co., L.P.$4033,3330.00%12qHELD
WOLVERINE ASSET MANAGEMENT LLC$2118,2390.00%12q+85.6%
LITTLEJOHN & CO LLC$20options only0.00%12qOPTIONS

Quarter by quarter

Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.

QuarterHoldersValue SharesNewAdded TrimmedOptions
Q2 202412$3.5K2,794,7900322.5%
Q1 202415$364.6K2,599,6881032.7%
Q4 202314$300.4K2,751,2461013.6%
Q3 202312$263.7K2,750,8960102.1%
Q2 202313$466.8K2,769,7012022.6%
Q1 202312$281.9K2,821,3771110.8%
Q4 202213$328.7K2,850,7942110.8%
Q3 202213$548.0K2,893,4860132.6%
Q2 202218$814.5K3,352,4171142.1%
Q1 202220$1.4M3,431,9141356.9%
Q4 202121$3.4M3,328,40024614.1%
Q3 202125$6.4M3,501,852250011.5%